Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 1, 2002

View Archived Issues

Bay-41-4109: a novel anti-HBV candidate

Cannabinoids may not improve symptoms of multiple sclerosis

Safe transition from i.v. epoprostenol to s.c. treprostinil in patients with PAH

Therapeutic angiogenic effects of rFGF-2 in patients with intermittent claudication

CVT-3146 set to enter phase III in 2003

Eligix CD8-SC Cell Separation System approved in E.U.

Fujisawa announces microbial research agreement with MerLion

Fujirebio acquires rights to ovarian tumor markers

Amersham Biosciences and Sloan-Kettering Institute collaborate to scan human genome

Immune Network and AbNovo to develop antibody-based therapeutics for viral diseases

Levaquin sNDA submitted for chronic bacterial prostatitis

Incara's IND for liver cell therapy approved

Zonagen awarded SBIR grant for Progenta in breast cancer

Bristol-Myers Squibb researchers identify CDK-inhibitory semicarbazides

Japanese, American and British scientists jointly describe new PI3K inhibitors

New CDK inhibitors in early development at BMS

Roche presents A2A antagonists with potential in depression and other disorders

Versicor and Biosearch Italia to merge

Aventis describes novel factor Xa/VIIa inhibitors and their use

Novel tryptase inhibitors emerge from Boehringer Ingelheim